SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Momenta Pharmaceuticals Inc.
An SI Board Since March 2004
Posts SubjectMarks Bans Symbol
3027 64 0 MNTA
Emcee:  michael_f_murphy Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2502?? You said ""I'm getting the feeling that people here and on iHuJeffry K. Smith-9/16/2010
2501<i> I haven't gotten the impression that the information on IH is unavtom pope-9/16/2010
2500"I'm getting the feeling that people here and on iHub are reading a difJeffry K. Smith19/16/2010
2499Per Genisi, Teva does not have the magic sauce. So why is MNTA laboring at the stom pope-9/16/2010
2498The real question is how much you trust the public statements of the TEVA's Biomaven-9/16/2010
2497I'm getting the feeling that people here and on iHub are reading a differenttom pope-9/16/2010
2496Interesting post from IH: genisi Thursday, September 16, 2010 6:48:33 AM IRWIN JAMES FRANKEL-9/16/2010
2495Tuck, cytokine profiing or cytokine-secretion profies are in vitro assays used iidos-9/14/2010
2494Re: "Copolymer Assay" Notable excerpt: "The present invention prtuck-9/14/2010
2493So, I think we both agree that proving inequitable conduct is quite tough and thidos-9/14/2010
2492[A Computational Approach for Deciphering the Organization of Glycosaminoglycanstuck-9/14/2010
2491Momenta Pharmaceuticals Awarded U.S. Patent for Evaluating Mixtures of Low Molectnsaf-9/13/2010
2490Prior art and obviousness of the advance over COP1 will be central the the decisIRWIN JAMES FRANKEL19/13/2010
2489Maybe I'm pointing to the obvious but Teva might try to get summary judgmentidos-9/13/2010
2488MNTA ‘ReadMeFirst’ updated: <i>change in BoD from resignation of Ram SasiDewDiligence_on_SI-9/12/2010
2487Thanks for your reply. Very interesting! "PS - I have friend named JefferJeffry K. Smith-9/11/2010
2486"Axe" in this context says the analyst is the best and recognized as sIRWIN JAMES FRANKEL-9/11/2010
2485What do you mean by "the axe in the name"? Thanks. >eom<Jeffry K. Smith-9/11/2010
2484" This guy Ronny Gal seems to be the axe in the name for now" Aaron (idos-9/11/2010
2483MNTA ‘ReadMeFirst’ updated: <i>latest IMS data for branded and generic LoDewDiligence_on_SI-9/8/2010
2482I don't think the IMS data even reflects major hospital contracts, at least tuck-9/7/2010
2481Thanks. The total stayed near 54K weekly. Shouldn't there have been an incIan@SI-9/7/2010
2480Updated IMS data for those who don't frequent IHub: siliconinvestor.com Chtuck-9/7/2010
2479I have to agree with Dew here: the FDA must have had some way around this in mintuck19/7/2010
2478IJ, agreed that by statements such as "A finding of sameness does not, howeidos-9/7/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News